Luskin A, Griffin NM, Wagele-Steffen A, et al. Decreased exacerbations and hospitalizations in adolescents enrolled in PROSPERO (Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). ATS 2017, abstract A5104.
Verminderde ademhalingsefficiëntie kan dyspneu veroorzaken, zelf bij milde COPD
jun 2022 | COPD